Global healthcare knowledge provider BMJ has partnered with the European Society for Medical Oncology (ESMO), with the aim of publishing a new open access cancer journal (ESMO Open) from next year, the company has announced.
ESMO has over 10,000 members from over 130 countries, working in cancer care and research, and the new title will be its second official journal after the Annals of Oncology.
ESMO Open represents a first in this field for BMJ, which now has a stable of more than 50 peer reviewed specialist and open access journals in addition to its flagship title The BMJ.
The new title will publish original research covering the full spectrum of cancer treatment, including medical, radiation, and surgical oncology.
And in common with BMJ's other open access titles, ESMO Open will include a wide range of material that isn't always available in more traditional outlets, including study protocols and phase I clinical trials, meta-analyses, small or specialist studies, and interesting case studies.
ESMO Open will also offer a platform for ESMO and other partner societies at national and international level to publish important policy papers for sharing with the cancer care community at large.
The title will operate a fast submission and review process, with continuous publication online, ensuring that up to date high quality research is rapidly available worldwide.
BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. A full list of BMJ products and services is available here: bmj.com
ESMO is the leading European professional organisation committed to advancing the specialty of medical oncology and promoting an integrated approach to cancer treatment and care. With its extensive international membership, ESMO represents an ideal platform for oncologists to network, update their knowledge, and improve their practice. For more information, please visit: http://www.